These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10655995)

  • 1. An analysis of relative costs and potential benefits of different policies for antenatal screening for beta thalassaemia trait and variant haemoglobins.
    Phelan L; Bain BJ; Roper D; Jury C; Bain K
    J Clin Pathol; 1999 Sep; 52(9):697-700. PubMed ID: 10655995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The laboratory diagnosis of haemoglobinopathies.
    Br J Haematol; 1998 Jun; 101(4):783-92. PubMed ID: 9674756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme.
    Griffin M; Eyre J; Dack S; Wright J
    J Clin Pathol; 2015 May; 68(5):388-90. PubMed ID: 25694443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening criteria for beta thalassaemia trait in pregnant women.
    Rogers M; Phelan L; Bain B
    J Clin Pathol; 1995 Nov; 48(11):1054-6. PubMed ID: 8543631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme.
    Cronin EK; Normand C; Henthorn JS; Graham V; Davies SC
    BJOG; 2000 Apr; 107(4):486-91. PubMed ID: 10759267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costing model for neonatal screening and diagnosis of haemoglobinopathies.
    Cronin EK; Normand C; Henthorn JS; Hickman M; Davies SC
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F161-7. PubMed ID: 10194984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.
    Bain BJ
    J Clin Pathol; 1988 May; 41(5):481-5. PubMed ID: 3384979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders.
    Bain BJ; Chapman C
    J Clin Pathol; 1998 May; 51(5):382-9. PubMed ID: 9708206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Thalassaemia Screening Tests in the Antenatal and Non-Antenatal Populations in Singapore.
    Lee SY; Yap ES; Lee EY; Goh JH; Liu TC; Yip C
    Ann Acad Med Singap; 2019 Jan; 48(1):5-15. PubMed ID: 30788489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.
    Daniel Y; Cartwright R; Rennie K; Streetly A; Howard J
    Br J Haematol; 2014 Aug; 166(4):607-11. PubMed ID: 24754789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalassaemia screening in pregnancy.
    Leung TN; Lau TK; Chung TKh
    Curr Opin Obstet Gynecol; 2005 Apr; 17(2):129-34. PubMed ID: 15758603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated computer result reporting for haemoglobinopathy screening.
    Daniel Y; Witchlow B; Almeida A
    Clin Lab Haematol; 2004 Feb; 26(1):21-4. PubMed ID: 14738433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemoglobinopathies and patients with foreign names].
    Lilleholt K; Hallberg MH; Hagve TA
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1164-7. PubMed ID: 15880152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S; Sirichotiyakul S; Srisupundit K; Tongsong T
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for beta thalassaemia and HbE traits with the mean red cell volume in pregnant women.
    Yeo GS; Tan KH; Liu TC
    Ann Acad Med Singap; 1994 May; 23(3):363-6. PubMed ID: 7944251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid mid-trimester prenatal diagnosis of beta-thalassaemia and other haemoglobinopathies using a non-radioactive anion exchange HPLC technique--an Indian experience.
    Rao VB; Natrajan PG; Lulla CP; Bandodkar SB
    Prenat Diagn; 1997 Aug; 17(8):725-31. PubMed ID: 9267895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of discriminant functions in screening for beta-thalassaemia traits during pregnancy.
    Yeo GS; Tan KH; Liu TC
    Singapore Med J; 1995 Dec; 36(6):615-8. PubMed ID: 8781633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis.
    Zeuner D; Ades AE; Karnon J; Brown J; Dezateux C; Anionwu EN
    Health Technol Assess; 1999; 3(11):i-v, 1-186. PubMed ID: 10516927
    [No Abstract]   [Full Text] [Related]  

  • 19. Proposed screening criteria for beta-thalassemia trait during early pregnancy in southern China.
    Liao C; Xie XM; Zhong HZ; Zhou JY; Li DZ
    Hemoglobin; 2009; 33(6):528-33. PubMed ID: 19958202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong.
    Leung KY; Lee CP; Tang MH; Lau ET; Ng LK; Lee YP; Chan HY; Ma ES; Chan V
    Prenat Diagn; 2004 Nov; 24(11):899-907. PubMed ID: 15565640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.